Concepedia

Sean Keegan

SK

Statistics

Publications

9

Citations

464

H-Index

9

Active since

2003

Affiliations

Pfizer (United States)(Current)

Sean Keegan is an author at Pfizer (United States) specializing in immunology, life sciences, and b cell biology.

Publications per year

2003–2023

9

Publications

9

Selective Inhibition of BTK Prevents Murine Lupus and Antibody-Mediated Glomerulonephritis

Andrew L. Rankin, Nilufer P. Seth, Sean Keegan et al. · The Journal of Immunology · 2013 · 109 citations

, , +17

IL-21 Receptor Is Required for the Systemic Accumulation of Activated B and T Lymphocytes in MRL/MpJ-Fas<i>lpr/lpr</i>/J Mice

Andrew L. Rankin, Heath Guay, Deborah Herber et al. · The Journal of Immunology · 2012 · 79 citations · Full text

, , +17

IL-21 Receptor Is Critical for the Development of Memory B Cell Responses

Andrew L. Rankin, Heather MacLeod, Sean Keegan et al. · The Journal of Immunology · 2010 · 68 citations · Full text

, , +16

Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis

Kyung‐Hee Kim, Andreas Maderna, Mark E. Schnute et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 63 citations · Full text

, , +10

Enhanced <scp>GITR</scp>/<scp>GITRL</scp> interactions augment <scp>IL</scp>‐27 expression and induce <scp>IL</scp>‐10‐producing Tr‐1 like cells

Yijun Carrier, Matthew J. Whitters, Joy Miyashiro et al. · European Journal of Immunology · 2012 · 46 citations

, , +17

1–5 of 9